Loading organizations...
Loading organizations...
Innovative prodrug technology platform for unmet medical needs.
Ascendis Pharma was founded by Jan Møller Mikkelsen (Co-Founder, President and CEO).
Ascendis Pharma has raised $60.0M in total across 1 funding round.
Ascendis Pharma was founded by Jan Møller Mikkelsen (Co-Founder, President and CEO).
Ascendis Pharma has raised $60.0M in total across 1 funding round.
Ascendis Pharma's investors include Jonathan Silverstein, James Healy, Albert Cha, Janus Henderson Investors, RA Capital Management, Rock Springs Capital, Sectoral Asset Management, Sofinnova Partners, Venrock.
Key people at Ascendis Pharma.
Ascendis Pharma has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series D in December 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2021 | Visen Pharmaceuticals | $150.0M Series B | Hongshan Capital Group (Sequoia Capital China) | Qiming Venture Partners, Vivo Capital, Michael Wolff Jensen, CDG Capital, Cormorant Asset Management, HBM Healthcare Investments, Logos Capital, OrbiMed, Pivotal bioVenture Partners China, Sherpa Healthcare Partners, Sofinnova Ventures |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2014 | $60.0M Series D | Jonathan Silverstein, James Healy, Albert Cha | Janus Henderson Investors, RA Capital Management, Rock Springs Capital, Sectoral Asset Management, Sofinnova Partners, Venrock |
